AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35618613 — intervention group
Group type: COMPARATOR
Intervention: SBAR (Situation, Background, Assessment, Recommendation) used as routine practice in the control group.
Number of subjects: 65
Study 32979134 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical activity plus motivationally-enhanced behavioral counseling (PA + BC)
Number of subjects: 26
Study 32979134 — intervention group
Group type: COMPARATOR
Intervention: Supervised physical activity plus standard exercise counseling (PA + EC)
Number of subjects: 26
Study 32816313 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborn Behavioral Observations (NBO)
Number of subjects: 38
Study 32816313 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 38
Study 34489159 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids (100% gain targets)
Number of subjects: 25
Study 34489159 — intervention group
Group type: COMPARATOR
Intervention: Sham hearing aids (flat 30 dB HL)
Number of subjects: 25
Study 32141277 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein Isolate (WPI)
Number of subjects: 31
Study 32141277 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein Concentrate (WPC)
Number of subjects: 31
Study 32141277 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 31
Study 35262624 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC (41.5 °C, 75 mg/m2 of cisplatin, 90 minutes)
Number of subjects: 184
Study 35262624 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 184
Study 35262624 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC (Interval cytoreductive surgery after neoadjuvant chemotherapy)
Number of subjects: 184
Study 35262624 — intervention group
Group type: COMPARATOR
Intervention: Control (Interval cytoreductive surgery after neoadjuvant chemotherapy)
Number of subjects: 184
Study 35262624 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC (Primary cytoreductive surgery)
Number of subjects: 184
Study 35262624 — intervention group
Group type: COMPARATOR
Intervention: Control (Primary cytoreductive surgery)
Number of subjects: 184
Study 32529637 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG‐IUS
Number of subjects: 2511
Study 32529637 — intervention group
Group type: COMPARATOR
Intervention: Other medical therapy
Number of subjects: 2511
Study 36001055 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐rhG‐CSF
Number of subjects: 100
Study 36001055 — intervention group
Group type: COMPARATOR
Intervention: rhG‐CSF
Number of subjects: 100
Study 33589554 — intervention group
Group type: EXPERIMENTAL
Intervention: apremilast 20 mg twice daily
Number of subjects: 490
Study 33589554 — intervention group
Group type: EXPERIMENTAL
Intervention: apremilast 30 mg twice daily
Number of subjects: 490
Study 33589554 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 490
Study 2010180594 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (15 mg, twice a day for one month)
Number of subjects: 9
Study 2010180594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 35499481 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mmHg
Number of subjects: 138
Study 35499481 — intervention group
Group type: COMPARATOR
Intervention: 15 mmHg
Number of subjects: 138
Study 33560349 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r 400mg/100mg twice daily + RBT 150mg/day (Arm A)
Number of subjects: 71
Study 33560349 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r 800mg/200mg twice daily + RIF 600mg/day (Arm B)
Number of subjects: 71
Study 33560349 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r 400mg/100mg twice daily + RAL 400mg twice daily + RBT 150mg/day (Arm C)
Number of subjects: 71
Study 33560349 — intervention group
Group type: COMPARATOR
Intervention: Historical controls for LPV concentrations
Number of subjects: 71
Study 33975009 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 IgG antibody response
Number of subjects: 392
Study 33975009 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 IgG antibody levels
Number of subjects: 392
Study 33975009 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory B-cell response
Number of subjects: 392
Study 32522121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation during gestation through 2 years of age
Number of subjects: 0
Study 32522121 — intervention group
Group type: COMPARATOR
Intervention: Atole
Number of subjects: 0
Study 32522121 — intervention group
Group type: COMPARATOR
Intervention: Fresco
Number of subjects: 0
Study 34740631 — intervention group
Group type: EXPERIMENTAL
Intervention: AdV E4
Number of subjects: 500
Study 34740631 — intervention group
Group type: COMPARATOR
Intervention: AdV D8
Number of subjects: 500
Study 33241426 — intervention group
Group type: EXPERIMENTAL
Intervention: New Harmonic scalpel
Number of subjects: 100
Study 33241426 — intervention group
Group type: COMPARATOR
Intervention: Reused Harmonic scalpel
Number of subjects: 100
Study 33241426 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 34598835 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram or Nortriptyline for 26 weeks
Number of subjects: 90
Study 33839594 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy dog intervention prior to the exam
Number of subjects: 80
Study 33839594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapy dog intervention)
Number of subjects: 80
Study 32162735 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with eicosapentaenoic and docosahexaenoic acids
Number of subjects: 10
Study 32162735 — intervention group
Group type: COMPARATOR
Intervention: Untreated preterm subjects (control group)
Number of subjects: 10
Study 35764523 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix acupuncture
Number of subjects: 120
Study 35764523 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 120
Study 33573664 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multimodal Tai Chi rehabilitation program
Number of subjects: 52
Study 33573664 — intervention group
Group type: COMPARATOR
Intervention: Postoperative usual care
Number of subjects: 52
Study 34736855 — intervention group
Group type: EXPERIMENTAL
Intervention: DrugSorb-ATR device
Number of subjects: 120
Study 34736855 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 120
Study 33479188 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVL) with low-dose tacrolimus (Tac)
Number of subjects: 77
Study 33479188 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus (TAC)
Number of subjects: 77
Study 33479188 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVL)
Number of subjects: 77
Study 36027441 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Group (CG)
Number of subjects: 59
Study 36027441 — intervention group
Group type: COMPARATOR
Intervention: Peripheral Group (PG)
Number of subjects: 59
Study 36027441 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 59
Study 34193818 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid cycling (cycling with legs via electrical stimulation combined with voluntary handcycling)
Number of subjects: 10
Study 34193818 — intervention group
Group type: COMPARATOR
Intervention: Handcycling
Number of subjects: 10
Study 36071965 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic chewable tablet (5 × 10^9 CFU/day, n = 47)
Number of subjects: 92
Study 36071965 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 45)
Number of subjects: 92
Study 32539850 — intervention group
Group type: EXPERIMENTAL
Intervention: Hominis placental pharmacopuncture (HPP)
Number of subjects: 82
Study 32539850 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 82
Study 32539850 — intervention group
Group type: EXPERIMENTAL
Intervention: Hominis placental pharmacopuncture (HPP) and Physical therapy (PT)
Number of subjects: 82
Study 33477722 — intervention group
Group type: EXPERIMENTAL
Intervention: Planet Nutrition program (18 nutrition education sessions, 20 physical activity classes, 6 brochures for parents)
Number of subjects: 41
Study 33477722 — intervention group
Group type: EXPERIMENTAL
Intervention: Planet Nutrition program
Number of subjects: 41
Study 33477722 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 32978722 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 μg Buprenorphine Buccal Film (BBF)
Number of subjects: 19
Study 32978722 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 μg Buprenorphine Buccal Film (BBF)
Number of subjects: 19
Study 32978722 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 μg Buprenorphine Buccal Film (BBF)
Number of subjects: 19
Study 32978722 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg Oral Oxycodone
Number of subjects: 19
Study 32978722 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Oral Oxycodone
Number of subjects: 19
Study 32978722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 36198452 — intervention group
Group type: EXPERIMENTAL
Intervention: AVX001 gel 1%
Number of subjects: 60
Study 36198452 — intervention group
Group type: EXPERIMENTAL
Intervention: AVX001 gel 3%
Number of subjects: 60
Study 36198452 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 60
Study 33361618 — intervention group
Group type: EXPERIMENTAL
Intervention: 10Hz over the ipsilesional primary motor cortex (M1) and next 1Hz over the contralesional M1
Number of subjects: 100
Study 33361618 — intervention group
Group type: COMPARATOR
Intervention: Contralesional sham stimulation and next ipsilesional real 10Hz
Number of subjects: 100
Study 33361618 — intervention group
Group type: COMPARATOR
Intervention: Contralesional real 1Hz rTMS and next ipsilesional sham stimulation
Number of subjects: 100
Study 33361618 — intervention group
Group type: COMPARATOR
Intervention: Bilateral sham-control procedures
Number of subjects: 100
Study 32856605 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 8122
Study 32856605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8122
Study 36364734 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat product providing 3 g of β‐Glucan
Number of subjects: 0
Study 36364734 — intervention group
Group type: COMPARATOR
Intervention: Rice control group
Number of subjects: 0
Study 36189417 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based nursing education (12 sessions)
Number of subjects: 60
Study 36189417 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study 32988954 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-washing cloth masks by hand
Number of subjects: 607
Study 32988954 — intervention group
Group type: COMPARATOR
Intervention: Cloth masks washed in hospital laundry
Number of subjects: 607
Study 32988954 — intervention group
Group type: COMPARATOR
Intervention: Medical masks
Number of subjects: 607
Study 35243636 — intervention group
Group type: EXPERIMENTAL
Intervention: Three quarters of a 20-mm diameter, 5-mm thick tablet
Number of subjects: 89
Study 32735886 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavin adenine dinucleotide (FAD)
Number of subjects: 0
Study 34753412 — intervention group
Group type: EXPERIMENTAL
Intervention: betaxolol 0.5%
Number of subjects: 38
Study 34753412 — intervention group
Group type: COMPARATOR
Intervention: brimonidine 0.2%
Number of subjects: 38
Study 33640829 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (Laser irradiation using a GaAlAs diode laser at 810 nm, 27 J/cm2, 200 mW) applied on 12 points on malar area during 12 sessions within six weeks.
Number of subjects: 71
Study 33640829 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (Laser irradiation)
Number of subjects: 71
Study 33640829 — intervention group
Group type: COMPARATOR
Intervention: Control group (no photobiomodulation treatment)
Number of subjects: 71
Study 35172248 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 163
Study 35172248 — intervention group
Group type: COMPARATOR
Intervention: Brief Adolescent Mindfulness (BAM)
Number of subjects: 163
Study 35172248 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MI and BAM
Number of subjects: 163
Study 36330727 — intervention group
Group type: EXPERIMENTAL
Intervention: GrowEat project (nutrition intervention programme with home gardening activities); duration: 12 weeks.
Number of subjects: 134
Study 36330727 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention);
Number of subjects: 134
Study 32321389 — intervention group
Group type: EXPERIMENTAL
Intervention: CIDT training
Number of subjects: 491
Study 32321389 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 491
Study 35965283 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders with embedded interactive educational information
Number of subjects: 2086
Study 35965283 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2086
Study 33413153 — intervention group
Group type: EXPERIMENTAL
Intervention: Montessori-based activities
Number of subjects: 108
Study 32442355 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered attention control therapy (ACT)
Number of subjects: 119
Study 32442355 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual in the community
Number of subjects: 119
Study 35429294 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST-B
Number of subjects: 12
Study 35429294 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST-NB
Number of subjects: 12
Study 35429294 — intervention group
Group type: COMPARATOR
Intervention: CONV
Number of subjects: 12
Study 34872550 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on integrated HBM with HL (e-learning through social media, 4 times during 4 weeks, educational booklets and pamphlets)
Number of subjects: 140
Study 34872550 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 140
Study 33341828 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic oscillatory stretch technique
Number of subjects: 83
Study 33341828 — intervention group
Group type: COMPARATOR
Intervention: Static stretching technique
Number of subjects: 83
Study 35236083 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary cytoreduction in OC patients
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Primary cytoreduction in PPC patients
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Surgical complexity score
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Recurrence rates
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Progression-free survival (PFS)
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Overall survival (OS)
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Extraperitoneal disease and interval cytoreduction
Number of subjects: 220
Study 35236083 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal cytoreduction and delay in adjuvant chemotherapy
Number of subjects: 220
Study 34844563 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting prognosis of patients with CC
Number of subjects: 426
Study 32321516 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonimmersive VR games during exercise session
Number of subjects: 84
Study 32321516 — intervention group
Group type: COMPARATOR
Intervention: Control group (same exercises without VR games)
Number of subjects: 84
Study 35305678 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing sitting time to no more than 4 hours per day
Number of subjects: 0
Study 35305678 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing sitting time by approximately 36 minutes per person per day in adults who sit 4 or more hours per day
Number of subjects: 0
Study 33938830 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 F DLT
Number of subjects: 50
Study 33938830 — intervention group
Group type: COMPARATOR
Intervention: DLT based on height
Number of subjects: 50
Study 33938830 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 32536316 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision approach (group 1)
Number of subjects: 93
Study 32536316 — intervention group
Group type: COMPARATOR
Intervention: Dual-incision approach (group 2)
Number of subjects: 93
Study 35426492 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene (18 mg)
Number of subjects: 17
Study 35426492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 34326035 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment for SMZL
Number of subjects: 190
Study 34326035 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment for NMZL
Number of subjects: 190
Study 34326035 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenectomy for SMZL
Number of subjects: 190
Study 34326035 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic transformation (HT)
Number of subjects: 190
Study 34326035 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Survival (OS) for patients with HT
Number of subjects: 190
Study 34326035 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Survival (OS) for patients without HT
Number of subjects: 190
Study 34326035 — intervention group
Group type: COMPARATOR
Intervention: Overall Survival (OS) comparison
Number of subjects: 190
Study 34326035 — intervention group
Group type: COMPARATOR
Intervention: Time to First Systemic Treatment (TTFST)
Number of subjects: 190
Study 35178225 — intervention group
Group type: EXPERIMENTAL
Intervention: Information technology for care management
Number of subjects: 104
Study 35178225 — intervention group
Group type: COMPARATOR
Intervention: Conventional care methods
Number of subjects: 104
Study 33743237 — intervention group
Group type: EXPERIMENTAL
Intervention: Second intravenous immunoglobulin dose (SID) 2 g/kg over 5 days
Number of subjects: 93
Study 33743237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 32845800 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=51) completed questionnaires and participated in interventions to increase mortality awareness
Number of subjects: 98
Study 32845800 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=47) only completed the questionnaires
Number of subjects: 98
Study 32845800 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=51)
Number of subjects: 98
Study 32342840 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin mass drug administration (MDA)
Number of subjects: 0
Study 32342840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35761105 — intervention group
Group type: EXPERIMENTAL
Intervention: Same Days (SD) - Resistance training followed by HIIT
Number of subjects: 21
Study 35761105 — intervention group
Group type: EXPERIMENTAL
Intervention: Different Days (DD) - Resistance training on specific days and HIIT on alternate days
Number of subjects: 21
Study 35761105 — intervention group
Group type: COMPARATOR
Intervention: Control - Treatment as usual
Number of subjects: 21
Study 34429614 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIT+dupilumab (300 mg every 2 weeks)
Number of subjects: 103
Study 34429614 — intervention group
Group type: COMPARATOR
Intervention: SCIT alone
Number of subjects: 103
Study 34429614 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIT+dupilumab
Number of subjects: 103
Study 32944278 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-led manoeuvres
Number of subjects: 75
Study 32944278 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led exercises
Number of subjects: 75
Study 32944278 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice
Number of subjects: 75
Study 32944278 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 75
Study 34911042 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Daughters Moving Together intervention
Number of subjects: 31
Study 34911042 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 31
Study 36217830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention emphasizing belief disconfirmation (CbI)
Number of subjects: 59
Study 36217830 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention emphasizing exposure (BI)
Number of subjects: 59
Study 36217830 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 59
Study 33881530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate (250 to 1500 mg/d)
Number of subjects: 97
Study 33881530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 36294478 — intervention group
Group type: EXPERIMENTAL
Intervention: HT‐PTI
Number of subjects: 45
Study 36294478 — intervention group
Group type: COMPARATOR
Intervention: FHT
Number of subjects: 45
Study 34050261 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionising radiation exposure (mean ABM dose 0.14 Gy)
Number of subjects: 143136
Study 34050261 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionising radiation exposure
Number of subjects: 143136
Study 32307658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I) including sleep hygiene information, stimulus control, sleep restriction, and bedtime imagery audio recording.
Number of subjects: 93
Study 32307658 — intervention group
Group type: COMPARATOR
Intervention: Control group with similar interventions but without sleep restriction and using audio recordings of bedtime short stories.
Number of subjects: 93
Study 32307658 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 93
Study 33855642 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupressure (TAP)
Number of subjects: 0
Study 33855642 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham acupressure (SAP)
Number of subjects: 0
Study 33855642 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard care (ESC)
Number of subjects: 0
Study 33248986 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimlanod 6 μg/kg/min
Number of subjects: 322